Cargando…

Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an inflammatory neuropathy, classically characterised by a slowly progressive onset and symmetrical, sensorimotor involvement. However, there are many phenotypic variants, suggesting that CIDP may not be a discrete disease entity bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathey, Emily K, Park, Susanna B, Hughes, Richard A C, Pollard, John D, Armati, Patricia J, Barnett, Michael H, Taylor, Bruce V, Dyck, P James B, Kiernan, Matthew C, Lin, Cindy S-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552934/
https://www.ncbi.nlm.nih.gov/pubmed/25677463
http://dx.doi.org/10.1136/jnnp-2014-309697
_version_ 1782387817458958336
author Mathey, Emily K
Park, Susanna B
Hughes, Richard A C
Pollard, John D
Armati, Patricia J
Barnett, Michael H
Taylor, Bruce V
Dyck, P James B
Kiernan, Matthew C
Lin, Cindy S-Y
author_facet Mathey, Emily K
Park, Susanna B
Hughes, Richard A C
Pollard, John D
Armati, Patricia J
Barnett, Michael H
Taylor, Bruce V
Dyck, P James B
Kiernan, Matthew C
Lin, Cindy S-Y
author_sort Mathey, Emily K
collection PubMed
description Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an inflammatory neuropathy, classically characterised by a slowly progressive onset and symmetrical, sensorimotor involvement. However, there are many phenotypic variants, suggesting that CIDP may not be a discrete disease entity but rather a spectrum of related conditions. While the abiding theory of CIDP pathogenesis is that cell-mediated and humoral mechanisms act together in an aberrant immune response to cause damage to peripheral nerves, the relative contributions of T cell and autoantibody responses remain largely undefined. In animal models of spontaneous inflammatory neuropathy, T cell responses to defined myelin antigens are responsible. In other human inflammatory neuropathies, there is evidence of antibody responses to Schwann cell, compact myelin or nodal antigens. In this review, the roles of the cellular and humoral immune systems in the pathogenesis of CIDP will be discussed. In time, it is anticipated that delineation of clinical phenotypes and the underlying disease mechanisms might help guide diagnostic and individualised treatment strategies for CIDP.
format Online
Article
Text
id pubmed-4552934
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45529342015-09-02 Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype Mathey, Emily K Park, Susanna B Hughes, Richard A C Pollard, John D Armati, Patricia J Barnett, Michael H Taylor, Bruce V Dyck, P James B Kiernan, Matthew C Lin, Cindy S-Y J Neurol Neurosurg Psychiatry Neuro-Inflammation Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an inflammatory neuropathy, classically characterised by a slowly progressive onset and symmetrical, sensorimotor involvement. However, there are many phenotypic variants, suggesting that CIDP may not be a discrete disease entity but rather a spectrum of related conditions. While the abiding theory of CIDP pathogenesis is that cell-mediated and humoral mechanisms act together in an aberrant immune response to cause damage to peripheral nerves, the relative contributions of T cell and autoantibody responses remain largely undefined. In animal models of spontaneous inflammatory neuropathy, T cell responses to defined myelin antigens are responsible. In other human inflammatory neuropathies, there is evidence of antibody responses to Schwann cell, compact myelin or nodal antigens. In this review, the roles of the cellular and humoral immune systems in the pathogenesis of CIDP will be discussed. In time, it is anticipated that delineation of clinical phenotypes and the underlying disease mechanisms might help guide diagnostic and individualised treatment strategies for CIDP. BMJ Publishing Group 2015-09 2015-02-12 /pmc/articles/PMC4552934/ /pubmed/25677463 http://dx.doi.org/10.1136/jnnp-2014-309697 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Neuro-Inflammation
Mathey, Emily K
Park, Susanna B
Hughes, Richard A C
Pollard, John D
Armati, Patricia J
Barnett, Michael H
Taylor, Bruce V
Dyck, P James B
Kiernan, Matthew C
Lin, Cindy S-Y
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title_full Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title_fullStr Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title_full_unstemmed Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title_short Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
title_sort chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
topic Neuro-Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552934/
https://www.ncbi.nlm.nih.gov/pubmed/25677463
http://dx.doi.org/10.1136/jnnp-2014-309697
work_keys_str_mv AT matheyemilyk chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT parksusannab chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT hughesrichardac chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT pollardjohnd chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT armatipatriciaj chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT barnettmichaelh chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT taylorbrucev chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT dyckpjamesb chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT kiernanmatthewc chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype
AT lincindysy chronicinflammatorydemyelinatingpolyradiculoneuropathyfrompathologytophenotype